Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
6.03
-0.04 (-0.66%)
Nov 20, 2024, 4:00 PM EST - Market closed
Coya Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Coya Therapeutics stock have an average target of 16.67, with a low estimate of 14 and a high estimate of 18. The average target predicts an increase of 176.45% from the current stock price of 6.03.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for COYA stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +198.51% | Nov 11, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +132.17% | Nov 7, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +132.17% | Oct 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +198.51% | Sep 16, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +198.51% | Jun 13, 2024 |
Financial Forecast
Revenue This Year
5.01M
from 6.00M
Decreased by -16.51%
Revenue Next Year
7.73M
from 5.01M
Increased by 54.20%
EPS This Year
-1.34
from -0.79
EPS Next Year
-1.40
from -1.34
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 8.4M | 15.8M | 10.5M |
| Avg | 5.0M | 7.7M | 10.2M |
| Low | 3.5M | 2.4M | 9.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 39.9% | 214.3% | 35.9% |
| Avg | -16.5% | 54.2% | 32.0% |
| Low | -41.2% | -53.1% | 26.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.23 | -1.16 | -1.82 |
| Avg | -1.34 | -1.40 | -1.76 |
| Low | -1.49 | -1.61 | -1.70 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.